» Articles » PMID: 17230464

Punding Prevalence in Parkinson's Disease

Overview
Journal Mov Disord
Date 2007 Jan 19
PMID 17230464
Citations 30
Authors
Affiliations
Soon will be listed here.
Abstract

The purpose of this study was to determine punding prevalence in an ambulatory Parkinson's disease (PD) population. We conducted a patient-and-caregiver-completed punding survey in 373 consecutive patients in an academic ambulatory center. Completion rate was 78%. Only four patients were identified as punding. Patients did not retain insight to their behavior. Forty patients with high-dose levodopa monotherapy or levodopa and dopamine agonist treatment had physician-administered interview. None had punding. Punding incidence was low in this patient group (1.4%) in contrast with previous reports of 14%. Despite the low incidence, this behavior is disruptive and should be carefully elicited by physicians caring for Parkinson's disease patients.

Citing Articles

Emerging perspectives on precision therapy for Parkinson's disease: multidimensional evidence leading to a new breakthrough in personalized medicine.

Wang Q, Gu X, Yang L, Jiang Y, Zhang J, He J Front Aging Neurosci. 2024; 16:1417515.

PMID: 39026991 PMC: 11254646. DOI: 10.3389/fnagi.2024.1417515.


Magnetic Resonance Imaging Biomarkers of Punding in Parkinson's Disease.

Mao C, Zhang Y, Jiang J, Qin R, Ye Q, Zhu X Brain Sci. 2023; 13(10).

PMID: 37891792 PMC: 10605844. DOI: 10.3390/brainsci13101423.


Punding in Parkinson's Disease: An Update.

Rajalingam R, Fasano A Mov Disord Clin Pract. 2023; 10(7):1035-1047.

PMID: 37476310 PMC: 10354600. DOI: 10.1002/mdc3.13748.


Neuropsychiatric Features of Punding and Hobbyism in Parkinson's Disease.

Barbosa P, OSullivan S, Joyce E, Lees A, Warner T, Djamshidian A Mov Disord Clin Pract. 2022; 9(1):82-86.

PMID: 35005069 PMC: 8721828. DOI: 10.1002/mdc3.13363.


Further characterisation of psychosis-like behaviours induced by L-DOPA in the MPTP-lesioned marmoset.

Kwan C, Nuara S, Gourdon J, Huot P Naunyn Schmiedebergs Arch Pharmacol. 2021; 394(8):1685-1692.

PMID: 33963876 DOI: 10.1007/s00210-021-02090-6.